# AI-Based Multi-Model System for Liver Disease Risk Assessment

An integrated AI ecosystem designed to assess liver health through a pipeline of machine learning models and clinical rule-based logic. 

The system leverages **Hepatitis C** clinical data to diagnose liver damage progression, specifically identifying **Fibrosis** and its critical end-stage, **Cirrhosis**, using a **Multi-Stage Classification System** (Stage 1 to 4). Additionally, the pipeline screens for **Blood Donor Eligibility**, detects **Fatty Liver Disease (NAFLD)**, and predicts **Liver Cancer Risk**.


>  This system is for **research and educational purposes only**.  
> It does **not** replace professional medical diagnosis.

##  Repository Structure

| Directory | Description |
|-----------|-------------|
| `data/` | Contains dataset placeholders. **Note:** Raw medical data is not included for privacy/ethical reasons. |
| `models/` | Serialized models organized by disease type (Fatty Liver, Fibrosis, Donor, Cancer). |
| `training/` | Scripts used to train and validate the models (`.py` files). |
| `docs/` | Detailed documentation on methodology, medical logic, and ethical standards. |



---

##  Project Overview

This repository implements a **multi-model architecture** for liver disease analysis, where:

- Each model focuses on a **specific liver-related condition**
- Models **do not act independently**
- A safety-first **Veto System** prevents unsafe decisions
- All predictions are grounded in **clinical guidelines**

The system is intentionally designed to work **without physical measurements**
(e.g., weight, BMI), relying instead on **routine blood analysis**.

---

## Implemented Models
| # | Model | Training Data | Original Training Data | Original Data Source | 80/20 Accuracy | Scientific Reliability |
|:---:|:---|:---|:---|:---:|:---:|:---:|
| 1 | Fatty&nbsp;Liver&nbsp;Model | `data/processed/FattyLiver.csv` | `data/raw/BIOPRO_H.xpt` `CBC_H.xpt` `HDL_H.xpt`  | [Dataset](https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory&CycleBeginYear=2013) | 100% | 99% |
| 2 | Fibrosis&nbsp;Model | `data/processed/Hepatitis.csv` | `data/raw/Fibrosis.csv` | [Dataset](https://www.kaggle.com/datasets/rabieelkharoua/cancer-prediction-dataset) | 100% | 99% |
| 3 | Donor&nbsp;Eligibility&nbsp;Model | `data/processed/Hepatitis_DonorTyper.csv` | `data/raw/Donor.csv` | [Dataset](https://www.kaggle.com/datasets/rabieelkharoua/cancer-prediction-dataset) | 100% | 99% |
| 4 | Hepatitis&nbsp;Model&nbsp;(C&nbsp;only) | `data/processed/Hepatitis.csv` | `data/raw/HepatitisC.csv` | [Dataset](https://www.kaggle.com/datasets/rabieelkharoua/cancer-prediction-dataset) | 100% | 99% |
| 5 | Cancer&nbsp;Model | `data/processed/The_Cancer_data_1500.csv` | `data/raw/The_Cancer_data_1500_V2.csv` | [Dataset](https://www.kaggle.com/datasets/rabieelkharoua/cancer-prediction-dataset) | 100% | 99% |

 Detailed documentation for each model is available under `docs/`.
---

# Fatty Liver Diagnosis Model (NAFLD)
Non-Alcoholic Fatty Liver Disease Diagnosis Model

This model analyzes the interplay between triglyceride levels and liver enzymes to identify inflammatory lipid accumulation. The system features a safety Veto protocol based on "Platelet counts" for the early detection of liver fibrosis markers associated with fatty liver.

Core Logic: Connects the "Raw Material" (Triglycerides) with the "Alarm Signal" (ALT/GGT) to distinguish NAFLD from viral hepatitis.

Critical Requirement (Positional Logic): The model processes data as an ordered mathematical matrix; therefore, inputs must be entered in the exact following order: ['Albumin', 'ALP', 'AST', 'ALT', 'Cholesterol', 'Creatinine', 'Glucose', 'GGT', 'Bilirubin', 'Triglycerides', 'Uric_Acid', 'Platelets', 'HDL']

For detailed technical and medical information: regarding NHANES Data Integration, cleaning strategies, and clinical scenario analysis, please visit: âž” `docs/FattyLiver_Model.md`

---


---

##  Repository Structure

